The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula
1
and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
本发明涉及一种新颖的4-(1H-
苯并咪唑-2-基)[1,4]二
氮杂
环庚烷衍
生物及其立体异构体,以及其药学上可接受的盐,其作为
组胺受体
拮抗剂和速激肽受体
拮抗剂具有用途。这些
拮抗剂在过敏性鼻炎的治疗中有用,包括季节性鼻炎和鼻窦炎;炎症性肠病,包括克罗恩病和溃疡性结肠炎;哮喘;支气管炎;以及呕吐。